Intra-Cellular Ther
(ITCI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ITCI | MRNA | ASND | ||
| Company | Intra-Cellular Ther | Moderna Inc | Ascendis Pharma ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 131.90 | 42.87 | 221.54 | ||
| High | 131.98 | 45.50 | 225.19 | ||
| Low | 131.63 | 41.68 | 213.02 | ||
| Latest | 131.87 | 41.99 | 224.19 | ||
| Change | -0.05 | +0.04 | +2.16 | ||
| % Change | -0.04% | +0.10% | +0.97% | ||
| Volume | 16,062,900 | 9,957,101 | 967,200 | ||
| 20-Day Average Volume | 2,474,570 | 14,297,615 | 721,860 | ||
| Previous Close | 131.92 | 41.95 | 222.03 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 131.51 | 43.89 | 222.41 | ||
| 20-Day Raw Stochastic | 86.25% | 37.54% | 56.89% | ||
| 20-Day Relative Strength | 82.75 | 56.00 | 54.22 | ||
| Weighted Alpha | +83.21 | +47.29 | +52.78 | ||
| Today's Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 48% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 03/25/25 | -0.50% since 02/03/26 | -0.21% since 02/03/26 | ||
| Low | 131.63 on 04/01/25 | 39.50 on 02/06/26 | 212.70 on 02/06/26 | ||
| High | 131.98 on 04/01/25 | 45.50 on 02/10/26 | 227.18 on 02/05/26 | ||
| 1-Month | |||||
| %Chg | +2.86% since 02/28/25 | +22.42% since 01/09/26 | +10.44% since 01/09/26 | ||
| Low | 131.18 on 03/05/25 | 32.37 on 01/12/26 | 188.08 on 01/12/26 | ||
| High | 131.98 on 04/01/25 | 55.20 on 01/22/26 | 242.00 on 01/28/26 | ||
| 3-Month | |||||
| %Chg | +57.89% since 12/31/24 | +69.59% since 11/10/25 | +14.38% since 11/10/25 | ||
| Low | 80.82 on 01/07/25 | 22.28 on 11/21/25 | 188.07 on 11/13/25 | ||
| High | 131.98 on 04/01/25 | 55.20 on 01/22/26 | 242.00 on 01/28/26 | ||
| 6-Month | |||||
| %Chg | +81.51% since 10/01/24 | +60.76% since 08/08/25 | +17.08% since 08/08/25 | ||
| Low | 70.90 on 10/07/24 | 22.28 on 11/21/25 | 186.05 on 10/20/25 | ||
| High | 131.98 on 04/01/25 | 55.20 on 01/22/26 | 242.00 on 01/28/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 14,047,056 | 16,391,292 | 13,760,754 | ||
| Shares Outstanding, K | 106,522 | 390,734 | 61,977 | ||
| Annual Sales | 680,850,000 | 3,236,000,000 | 393,500,000 | ||
| Annual Net Income | -74,680,000 | -3,561,000,000 | -409,120,000 | ||
| Last Quarter Sales | 199,220,000 | 1,016,000,000 | 249,720,000 | ||
| Last Quarter Net Income | -16,890,000 | -200,000,000 | -71,290,000 | ||
| 60-Month Beta | 0.46 | 1.31 | 0.44 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 02/21/25 | -0.51 on 11/06/25 | -1.17 on 11/12/25 | ||
| Latest Earnings Date | 05/06/25 | 02/13/26 | 02/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||